SCHEMBL4782979

SCHEMBL4782979

COc1ccccc1CNC(=O)c1ccc2c(N3CCN(C)CC3)nn(C)c2c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.55
ALDH1A1 P00352 6/20 0.54
HPGD P15428 5/20 0.54
KDM4E B2RXH2 4/20 0.54
CYP2C19 P33261 3/20 0.54
CYP1A2 P05177 2/20 0.54
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
CYP3A4 P08684 1/20 0.52
MAPT P10636 3/20 0.50
NAMPT P43490 1/20 0.49
GAA P10253 1/20 0.49
HDAC1 Q13547 1/20 0.49
TP53 P04637 2/20 0.49
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
LMNA P02545 2/20 0.48
POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4781008 0.84 KMT2A (0.51) ALDH1A1HPGDKDM4ECYP2C19CYP1A2
SCHEMBL4807228 0.83 KDM4E (0.52) ALDH1A1HPGDKDM4ECYP2C19MEN1
SCHEMBL4785037 0.83 RAB9A (0.54) RAB9AALDH1A1HPGDKDM4ECYP2C19
SCHEMBL4784193 0.80 DDR1 (0.51) GAAHDAC1LMNA
SCHEMBL4785283 0.78 KDM4E (0.43) RAB9AALDH1A1HPGDKDM4EMEN1
SCHEMBL4783731 0.77 BRAF (0.51) ALDH1A1HPGDKDM4ECYP2C19CYP1A2
SCHEMBL4785545 0.76 ALDH1A1 (0.59) ALDH1A1HPGDKDM4ECYP2C19CYP1A2
SCHEMBL4785947 0.74 CHEK1 (0.45) ALDH1A1KDM4EMEN1KMT2ACYP3A4
SCHEMBL4782350 0.73 CHEK1 (0.44) ALDH1A1KDM4EMEN1KMT2ACYP3A4
SCHEMBL14173393 0.72 KMT2A (0.61) RAB9AALDH1A1HPGDKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080153810-A1 INDAZOLE DERIVATIVES USEFUL AS MELANIN CONCENTRATING RECEPTOR LIGANDS FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-06-26 US claimed
WO-2008061109-A2 INDAZOLE DERIVATIVES USEFUL AS MELANIN CONCENTRATING RECEPTOR LIGANDS FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-05-22 WO claimed
US-20080153810-A1 INDAZOLE DERIVATIVES USEFUL AS MELANIN CONCENTRATING RECEPTOR LIGANDS FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-06-26 US disclosed
US-20080153810-A1 INDAZOLE DERIVATIVES USEFUL AS MELANIN CONCENTRATING RECEPTOR LIGANDS FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-06-26 US disclosed
US-20080153810-A1 INDAZOLE DERIVATIVES USEFUL AS MELANIN CONCENTRATING RECEPTOR LIGANDS FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-06-26 US disclosed
WO-2008061109-A2 INDAZOLE DERIVATIVES USEFUL AS MELANIN CONCENTRATING RECEPTOR LIGANDS FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-05-22 WO disclosed
WO-2008061109-A2 INDAZOLE DERIVATIVES USEFUL AS MELANIN CONCENTRATING RECEPTOR LIGANDS FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153810-A1 INDAZOLE DERIVATIVES USEFUL AS MELANIN CONCENTRATING RECEPTOR LIGANDS MCHR1, MCHR2, MC1R RAB9A 1460/4885ALDH1A1 2090/4885HPGD 730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.